NIH-funded research R03 grant

Investigating how HIV proteins and alcohol affect brain inflammation

Official title: HIV Tat and alcohol-mediated activation of astrocytes involves ER stress/NLRP6 inflammasome axis

Funded at University of Nebraska Medical Center · NIH-11054690 · Data updated 2026-11-12

This study is looking at how HIV proteins and alcohol might affect brain inflammation and thinking skills in people living with HIV, to find ways to help improve their cognitive health.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2026
Funding year2025
Award (this year)$76,750
NIH project number5R03AA031444-02
Project IDNIH-11054690 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals over 21 years old who are living with HIV and have a history of alcohol use disorder.

Less likely to help

Patients who do not have HIV or alcohol use disorder may not benefit from this research.

What this research studies

This research explores the effects of HIV proteins, specifically the Transactivator of Transcription (Tat), and alcohol on brain inflammation in individuals living with HIV. It focuses on how these factors contribute to cognitive decline, known as HIV-associated neurocognitive disorders (HAND). The study examines the role of astrocytes, a type of brain cell, in this process and investigates whether alcohol exacerbates inflammation caused by HIV proteins. By understanding these mechanisms, the research aims to identify potential therapeutic targets for improving cognitive health in affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for cognitive decline in people living with HIV who also struggle with alcohol use disorder.

How similar studies have gone: Previous research has indicated that targeting neuroinflammation may be a promising approach for addressing cognitive decline in HIV-infected individuals, suggesting potential success for this study's approach.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Singh, Seema — University of Nebraska Medical Center
  • Study coordinator: Singh, Seema

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.